ID   KAT3_HUMAN              Reviewed;         454 AA.
AC   Q6YP21; B3KQ13; O95335; Q5JS27; Q5T9T7; Q5T9T8; Q6AI27; Q6ICW1;
AC   Q9BVY5;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   10-MAY-2017, entry version 118.
DE   RecName: Full=Kynurenine--oxoglutarate transaminase 3;
DE            EC=2.6.1.7;
DE   AltName: Full=Cysteine-S-conjugate beta-lyase 2;
DE            EC=4.4.1.13;
DE   AltName: Full=Kynurenine aminotransferase 3 {ECO:0000312|HGNC:HGNC:33238};
DE   AltName: Full=Kynurenine aminotransferase III;
DE            Short=KATIII;
DE   AltName: Full=Kynurenine--glyoxylate transaminase;
DE            EC=2.6.1.63;
DE   AltName: Full=Kynurenine--oxoglutarate transaminase III;
GN   Name=KYAT3 {ECO:0000312|HGNC:HGNC:33238}; Synonyms=CCBL2, KAT3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=16376499; DOI=10.1016/j.gene.2005.09.034;
RA   Yu P., Li Z., Zhang L., Tagle D.A., Cai T.;
RT   "Characterization of kynurenine aminotransferase III, a novel member
RT   of a phylogenetically conserved KAT family.";
RL   Gene 365:111-118(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 85-454 (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 144-454, AND VARIANT
RP   PRO-206.
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 165-338, AND VARIANT
RP   PRO-206.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-116, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 (ISOFORM 3), CLEAVAGE OF
RP   INITIATOR METHIONINE [LARGE SCALE ANALYSIS] (ISOFORM 3), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Catalyzes the irreversible transamination of the L-
CC       tryptophan metabolite L-kynurenine to form kynurenic acid (KA).
CC       May catalyze the beta-elimination of S-conjugates and Se-
CC       conjugates of L-(seleno)cysteine, resulting in the cleavage of the
CC       C-S or C-Se bond (By similarity). Has transaminase activity
CC       towards L-kynurenine, tryptophan, phenylalanine, serine, cysteine,
CC       methionine, histidine, glutamine and asparagine with glyoxylate as
CC       an amino group acceptor (in vitro). Has lower activity with 2-
CC       oxoglutarate as amino group acceptor (in vitro) (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + 2-oxoglutarate = 4-(2-
CC       aminophenyl)-2,4-dioxobutanoate + L-glutamate.
CC   -!- CATALYTIC ACTIVITY: An L-cysteine-S-conjugate + H(2)O = RSH +
CC       NH(3) + pyruvate.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + glyoxylate = 4-(2-aminophenyl)-
CC       2,4-dioxobutanoate + glycine.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6YP21-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6YP21-2; Sequence=VSP_025603, VSP_025604;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q6YP21-3; Sequence=VSP_042841;
CC         Note=Initiator Met-1 is removed. Contains a N-acetylserine at
CC         position 2. {ECO:0000244|PubMed:22814378};
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -!- CAUTION: The first non-coding exon of CCBL2 is in common with that
CC       of RBMXL1. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72959.1; Type=Frameshift; Positions=336; Evidence={ECO:0000305};
CC       Sequence=AAH00819.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=CAG29278.1; Type=Frameshift; Positions=336; Evidence={ECO:0000305};
CC       Sequence=CAI21695.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI21696.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI41339.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI41340.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY028624; AAK26163.1; -; mRNA.
DR   EMBL; CR627392; CAH10487.1; -; mRNA.
DR   EMBL; AK057176; BAG51875.1; -; mRNA.
DR   EMBL; AL445991; CAI41345.1; -; Genomic_DNA.
DR   EMBL; AL139416; CAI21695.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL445991; CAI21695.1; JOINED; Genomic_DNA.
DR   EMBL; AL445991; CAI41339.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL139416; CAI41339.1; JOINED; Genomic_DNA.
DR   EMBL; AL139416; CAI21696.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL445991; CAI21696.1; JOINED; Genomic_DNA.
DR   EMBL; AL445991; CAI41340.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL139416; CAI41340.1; JOINED; Genomic_DNA.
DR   EMBL; BC000819; AAH00819.1; ALT_INIT; mRNA.
DR   EMBL; AF091090; AAC72959.1; ALT_FRAME; mRNA.
DR   EMBL; CR450282; CAG29278.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS30766.1; -. [Q6YP21-1]
DR   CCDS; CCDS30767.1; -. [Q6YP21-3]
DR   RefSeq; NP_001008661.1; NM_001008661.2. [Q6YP21-1]
DR   RefSeq; NP_001008662.1; NM_001008662.2. [Q6YP21-3]
DR   UniGene; Hs.481898; -.
DR   ProteinModelPortal; Q6YP21; -.
DR   SMR; Q6YP21; -.
DR   BioGrid; 121128; 13.
DR   IntAct; Q6YP21; 6.
DR   MINT; MINT-1402454; -.
DR   STRING; 9606.ENSP00000260508; -.
DR   BindingDB; Q6YP21; -.
DR   ChEMBL; CHEMBL2046260; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; Q6YP21; -.
DR   PhosphoSitePlus; Q6YP21; -.
DR   BioMuta; CCBL2; -.
DR   DMDM; 74710502; -.
DR   EPD; Q6YP21; -.
DR   MaxQB; Q6YP21; -.
DR   PaxDb; Q6YP21; -.
DR   PeptideAtlas; Q6YP21; -.
DR   PRIDE; Q6YP21; -.
DR   Ensembl; ENST00000260508; ENSP00000260508; ENSG00000137944. [Q6YP21-1]
DR   Ensembl; ENST00000370491; ENSP00000359522; ENSG00000137944. [Q6YP21-3]
DR   GeneID; 56267; -.
DR   KEGG; hsa:56267; -.
DR   UCSC; uc001dmp.3; human. [Q6YP21-1]
DR   CTD; 56267; -.
DR   DisGeNET; 56267; -.
DR   GeneCards; KYAT3; -.
DR   HGNC; HGNC:33238; KYAT3.
DR   HPA; HPA026538; -.
DR   HPA; HPA027168; -.
DR   MIM; 610656; gene.
DR   neXtProt; NX_Q6YP21; -.
DR   OpenTargets; ENSG00000137944; -.
DR   PharmGKB; PA162381274; -.
DR   eggNOG; KOG0257; Eukaryota.
DR   eggNOG; COG0436; LUCA.
DR   GeneTree; ENSGT00650000093238; -.
DR   HOGENOM; HOG000223045; -.
DR   HOVERGEN; HBG008391; -.
DR   InParanoid; Q6YP21; -.
DR   KO; K00816; -.
DR   OMA; TEICVTC; -.
DR   OrthoDB; EOG091G06LU; -.
DR   PhylomeDB; Q6YP21; -.
DR   TreeFam; TF352342; -.
DR   BioCyc; MetaCyc:HS06422-MONOMER; -.
DR   BRENDA; 2.6.1.7; 2681.
DR   Reactome; R-HSA-71240; Tryptophan catabolism.
DR   GenomeRNAi; 56267; -.
DR   PRO; PR:Q6YP21; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000137944; -.
DR   CleanEx; HS_CCBL2; -.
DR   ExpressionAtlas; Q6YP21; baseline and differential.
DR   Genevisible; Q6YP21; HS.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0047804; F:cysteine-S-conjugate beta-lyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047315; F:kynurenine-glyoxylate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0016212; F:kynurenine-oxoglutarate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; IEA:Ensembl.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0070189; P:kynurenine metabolic process; ISS:UniProtKB.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 2.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR034612; KAT_III.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   PANTHER; PTHR43807:SF4; PTHR43807:SF4; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Aminotransferase;
KW   Complete proteome; Lyase; Polymorphism; Pyridoxal phosphate;
KW   Reference proteome; Transferase.
FT   CHAIN         1    454       Kynurenine--oxoglutarate transaminase 3.
FT                                /FTId=PRO_0000287704.
FT   BINDING      53     53       Substrate. {ECO:0000250}.
FT   BINDING      71     71       Substrate; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     218    218       Substrate. {ECO:0000250}.
FT   BINDING     429    429       Substrate. {ECO:0000250}.
FT   MOD_RES     116    116       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     116    116       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q71RI9}.
FT   MOD_RES     280    280       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   VAR_SEQ       1     34       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042841.
FT   VAR_SEQ     152    167       VILIVPFYDCYEPMVR -> YNACTVKFTNLKCTAG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_025603.
FT   VAR_SEQ     168    454       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_025604.
FT   VARIANT     206    206       S -> P (in dbSNP:rs1059370).
FT                                {ECO:0000269|Ref.6, ECO:0000269|Ref.7}.
FT                                /FTId=VAR_032352.
FT   CONFLICT    251    251       W -> R (in Ref. 7; CAG29278).
FT                                {ECO:0000305}.
SQ   SEQUENCE   454 AA;  51400 MW;  2059D4646058BBB3 CRC64;
     MFLAQRSLCS LSGRAKFLKT ISSSKILGFS TSAKMSLKFT NAKRIEGLDS NVWIEFTKLA
     ADPSVVNLGQ GFPDISPPTY VKEELSKIAA IDSLNQYTRG FGHPSLVKAL SYLYEKLYQK
     QIDSNKEILV TVGAYGSLFN TIQALIDEGD EVILIVPFYD CYEPMVRMAG ATPVFIPLRS
     KPVYGKRWSS SDWTLDPQEL ESKFNSKTKA IILNTPHNPL GKVYNREELQ VIADLCIKYD
     TLCISDEVYE WLVYSGNKHL KIATFPGMWE RTITIGSAGK TFSVTGWKLG WSIGPNHLIK
     HLQTVQQNTI YTCATPLQEA LAQAFWIDIK RMDDPECYFN SLPKELEVKR DRMVRLLESV
     GLKPIVPDGG YFIIADVSLL DPDLSDMKNN EPYDYKFVKW MTKHKKLSAI PVSAFCNSET
     KSQFEKFVRF CFIKKDSTLD AAEEIIKAWS VQKS
//
